338 related articles for article (PubMed ID: 33913039)
21. Pathology-associated change in levels and localization of SIDT2 in postmortem brains of Parkinson's disease and dementia with Lewy bodies patients.
Fujiwara Y; Kabuta C; Sano T; Murayama S; Saito Y; Kabuta T
Neurochem Int; 2022 Jan; 152():105243. PubMed ID: 34800582
[TBL] [Abstract][Full Text] [Related]
22. Mercury is present in neurons and oligodendrocytes in regions of the brain affected by Parkinson's disease and co-localises with Lewy bodies.
Pamphlett R; Bishop DP
PLoS One; 2022; 17(1):e0262464. PubMed ID: 35015796
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of pathological markers in Parkinson's disease dementia post-mortem brains compared to dementia with Lewy bodies.
Tu H; Zhang ZW; Qiu L; Lin Y; Jiang M; Chia SY; Wei Y; Ng ASL; Reynolds R; Tan EK; Zeng L
BMC Neurosci; 2022 Jan; 23(1):3. PubMed ID: 34983390
[TBL] [Abstract][Full Text] [Related]
24. Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD.
Francis PT
J Neurol; 2009 Aug; 256 Suppl 3():280-5. PubMed ID: 19711117
[TBL] [Abstract][Full Text] [Related]
25. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T
Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347
[TBL] [Abstract][Full Text] [Related]
26. LRP10 in autosomal-dominant Parkinson's disease.
Chen Y; Cen Z; Zheng X; Pan Q; Chen X; Zhu L; Chen S; Wu H; Xie F; Wang H; Yang D; Wang L; Zhang B; Luo W
Mov Disord; 2019 Jun; 34(6):912-916. PubMed ID: 30964957
[TBL] [Abstract][Full Text] [Related]
27. HSP90 and Its Novel Co-Chaperones, SGT1 and CHP-1, in Brain of Patients with Parkinson's Disease and Dementia with Lewy Bodies.
Bohush A; Niewiadomska G; Weis S; Filipek A
J Parkinsons Dis; 2019; 9(1):97-107. PubMed ID: 30741686
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylated NUB1 distinguishes α-synuclein in Lewy bodies from that in glial cytoplasmic inclusions in multiple system atrophy.
Tanji K; Miki Y; Mori F; Kon T; Kakita A; Takahashi H; Wakabayashi K
Brain Pathol; 2019 Nov; 29(6):803-812. PubMed ID: 31006160
[TBL] [Abstract][Full Text] [Related]
29. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
Iwatsubo T
Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
[TBL] [Abstract][Full Text] [Related]
30. Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy Bodies.
Moors TE; Paciotti S; Ingrassia A; Quadri M; Breedveld G; Tasegian A; Chiasserini D; Eusebi P; Duran-Pacheco G; Kremer T; Calabresi P; Bonifati V; Parnetti L; Beccari T; van de Berg WDJ
Mol Neurobiol; 2019 Feb; 56(2):1344-1355. PubMed ID: 29948939
[TBL] [Abstract][Full Text] [Related]
31. Activated microglial cells and complement factors are unrelated to cortical Lewy bodies.
Rozemuller AJ; Eikelenboom P; Theeuwes JW; Jansen Steur EN; de Vos RA
Acta Neuropathol; 2000 Dec; 100(6):701-8. PubMed ID: 11078223
[TBL] [Abstract][Full Text] [Related]
32. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
33. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
Piggott MA; Ballard CG; Dickinson HO; McKeith IG; Perry RH; Perry EK
Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
[TBL] [Abstract][Full Text] [Related]
34. Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders.
Patterson L; Rushton SP; Attems J; Thomas AJ; Morris CM
Brain Pathol; 2019 Jul; 29(4):544-557. PubMed ID: 30582885
[TBL] [Abstract][Full Text] [Related]
35. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
36. Lewy-like aggregation of α-synuclein reduces protein phosphatase 2A activity in vitro and in vivo.
Wu J; Lou H; Alerte TN; Stachowski EK; Chen J; Singleton AB; Hamilton RL; Perez RG
Neuroscience; 2012 Apr; 207():288-97. PubMed ID: 22326202
[TBL] [Abstract][Full Text] [Related]
37. Dementia with Lewy bodies showing advanced Lewy pathology but minimal Alzheimer pathology--Lewy pathology causes neuronal loss inducing progressive dementia.
Uchikado H; Iseki E; Tsuchiya K; Togo T; Katsuse O; Uéda K; Kato M; Kosaka K
Clin Neuropathol; 2002; 21(6):269-77. PubMed ID: 12489676
[TBL] [Abstract][Full Text] [Related]
38. Formation and development of Lewy pathology: a critical update.
Jellinger KA
J Neurol; 2009 Aug; 256 Suppl 3():270-9. PubMed ID: 19711116
[TBL] [Abstract][Full Text] [Related]
39. Immunoreactivity of myelin-associated oligodendrocytic basic protein in Lewy bodies.
Kon T; Tanji K; Mori F; Kimura A; Kakita A; Wakabayashi K
Neuropathology; 2019 Aug; 39(4):279-285. PubMed ID: 31183926
[TBL] [Abstract][Full Text] [Related]
40. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease.
Iannaccone S; Cerami C; Alessio M; Garibotto V; Panzacchi A; Olivieri S; Gelsomino G; Moresco RM; Perani D
Parkinsonism Relat Disord; 2013 Jan; 19(1):47-52. PubMed ID: 22841687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
